Screening of an FDA-approved drug library reveals MEK1/2 inhibitors block production of osteoarthritis mediators in activated human chondrocytes and synovial fibroblasts.
| Publicado en: | Osteoarthritis & Cartilage Vol. 34; no. 6; pp. 806 - 819 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
Elsevier B.V.
Jun2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=193863893&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 193863893 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10634584 NZV jtl: Osteoarthritis & Cartilage issn: 10634584 maglogo: N pubinfo: dt: Jun2026 vid: 34 iid: 6 pid: 467 pub: Elsevier B.V. place: New York, New York artinfo: ui: 193863893 10.1016/j.joca.2026.03.116 193863893 ppf: 806 ppct: 13 formats: tig: atl: Screening of an FDA-approved drug library reveals MEK1/2 inhibitors block production of osteoarthritis mediators in activated human chondrocytes and synovial fibroblasts. aug: au: Coryell, Philip R. Fernandez Davila, Jorge G. Yanke, Adam B. Pearce, Kenneth H. Loeser, Richard F. affil: Thurston Arthritis Research Center, School of Medicine, University of North Carolina, Chapel Hill, NC, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|